SMTI
Sanara MedTech Inc. NASDAQ$19.73
Mkt Cap $170.1M
52w Low $16.05
18.5% of range
52w High $35.95
50d MA $18.95
200d MA $24.72
P/E (TTM)
-4.5x
EV/EBITDA
19.7x
P/B
28.7x
Debt/Equity
8.1x
ROE
-632.5%
P/FCF
93.2x
RSI (14)
—
ATR (14)
—
Beta
1.10
50d MA
$18.95
200d MA
$24.72
Avg Volume
63.6K
About
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts ext…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | AMC | 0.11 | 0.04 | -63.6% | 18.08 | +0.3% | -9.6% | -0.4% | -6.2% | -4.4% | -5.0% | +5.8% | — |
| Nov 12, 2025 | AMC | -0.24 | 0.09 | +137.5% | 21.11 | -0.5% | -7.1% | +2.0% | -0.2% | -1.0% | -9.7% | +22.7% | — |
| Aug 13, 2025 | AMC | -0.33 | -0.23 | +30.3% | 31.92 | -0.7% | -4.8% | -7.0% | -1.1% | -3.3% | -3.7% | +6.4% | — |
| May 14, 2025 | AMC | -0.31 | -0.41 | -32.3% | 31.30 | +2.1% | -1.3% | +0.6% | -0.4% | -0.8% | -0.9% | -8.0% | — |
| Mar 25, 2025 | AMC | -0.19 | -0.18 | +5.3% | 31.20 | +1.3% | -5.0% | +0.1% | -3.2% | -1.1% | -2.7% | +2.5% | — |
| Nov 12, 2024 | AMC | -0.62 | -0.34 | +45.2% | 34.60 | +2.6% | +7.6% | +4.0% | +0.1% | +2.2% | +6.8% | +3.6% | — |
| Aug 12, 2024 | AMC | -0.21 | -0.41 | -95.2% | 27.83 | +1.5% | +15.1% | +17.6% | +18.6% | +16.5% | +17.6% | +20.4% | — |
| May 13, 2024 | AMC | -0.07 | -0.21 | -200.0% | 29.28 | -1.7% | +2.0% | +16.3% | +8.3% | +4.2% | +11.1% | +6.8% | — |
| Mar 25, 2024 | AMC | -0.13 | -0.03 | +76.9% | 36.25 | +1.4% | +1.4% | +2.9% | +2.1% | +0.6% | -2.9% | -10.3% | — |
| Nov 13, 2023 | AMC | -0.13 | -0.13 | +0.0% | 28.57 | -1.6% | +19.4% | +17.6% | +15.5% | +15.8% | +11.3% | +38.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.75 | $21.75 | +0.0% | -2.3% | -4.4% | -1.7% | -3.2% | +1.1% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $19.61 | $19.61 | +0.0% | +9.8% | +7.4% | +6.6% | -2.8% | -2.4% |
| Aug 18 | HC Wainwright& Co. | Maintains | Buy → Buy | — | $29.68 | $30.35 | +2.3% | +6.4% | +4.0% | +3.5% | +2.8% | +14.4% |
| Aug 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $29.68 | $30.35 | +2.3% | +6.4% | +4.0% | +3.5% | +2.8% | +14.4% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $31.30 | $31.96 | +2.1% | -1.3% | +0.6% | -0.4% | -0.8% | -0.9% |
| Mar 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $31.20 | $31.60 | +1.3% | -5.0% | +0.1% | -3.2% | -1.1% | -2.7% |
| Mar 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $31.20 | $31.60 | +1.3% | -5.0% | +0.1% | -3.2% | -1.1% | -2.7% |
| Jan 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $37.72 | $38.04 | +0.8% | +1.1% | -1.6% | -2.7% | -0.2% | -3.7% |
| Jan 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $37.72 | $38.04 | +0.8% | +1.1% | -1.6% | -2.7% | -0.2% | -3.7% |
| Jan 22 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $34.00 | $37.00 | +8.8% | +10.9% | +12.1% | +9.2% | +7.9% | +10.7% |
Recent Filings
8-K
Unknown — 8-K Filing
Sanara MedTech's reaffirmed 2026 guidance signals management confidence in execution despite Q4 results, suggesting the stock may stabilize if investors believe growth targets are achievable.
Mar 24
8-K · 7.01
! Medium
Sanara MedTech Inc. -- 8-K 7.01: Regulation FD Disclosure
Sanara MedTech disclosed its 2026 priorities, strategy, and revenue expectations through a regulatory presentation, signaling management's strategic direction to investors for the upcoming fiscal year.
Mar 2
Data updated apr 27, 2026 2:00am
· Source: massive.com